CPIG
CRL icon

Chicago Partners Investment Group’s Charles River Laboratories CRL Stock Holding History

Chicago Partners Investment Group’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$442K Sell
1,927
-240
-11% -$42.7K 0.01% 1066
2026
Q1 		$400K Sell
2,167
-412
-16% -$76.4K 0.01% 1001
2025
Q4 		$566K Sell
2,579
-188
-7% -$34.1K 0.01% 697
2025
Q3 		$520K Buy
2,767
+890
+47% +$141K 0.01% 683
2025
Q2 		$315K Buy
+1,877
New +$250K 0.01% 812

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Chicago Partners Investment Group's CRL Position: Q2 2026 in Review

Chicago Partners Investment Group reduced its Charles River Laboratories (CRL) stake by 11% in Q2 2026, selling an estimated $42.7K and leaving 1,927 shares worth $442K. The position accounts for 0.01% of the portfolio, ranked #1066.

Chicago Partners Investment Group first reported a position in CRL in Q2 2025 and has held it in 5 quarters since. The position peaked at $566K in Q4 2025. 565 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Chicago Partners Investment Group held 1,927 shares of Charles River Laboratories worth $442K as of Q2 2026.
  • Chicago Partners Investment Group sold 240 Charles River Laboratories shares in Q2 2026, an estimated $42.7K.
  • Charles River Laboratories made up 0.01% of Chicago Partners Investment Group's portfolio in Q2 2026, its #1066 holding.
  • Chicago Partners Investment Group first reported a position in Charles River Laboratories in Q2 2025 and has held it in 5 quarters since.
  • Chicago Partners Investment Group's Charles River Laboratories position peaked at $566K in Q4 2025.
  • 565 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Chicago Partners Investment Group's 13F filing for Q2 2026, filed 30 Jul 2026.